Ascendis Pharma Grants 35,890 Warrants to Employees
Ascendis Pharma A/S announced the grant of 35,890 warrants to certain employees on October 13, 2026. The warrants have an exercise price of US $223.21 per share and vest over time, with 25% vesting after one year and the remainder vesting monthly thereafter, subject to continued service and exit events. The company also amended its Articles of Association to facilitate these grants. Following this grant, there are approximately 1,459,173 shares available for future warrant grants.
Key Highlights
- Ascendis Pharma A/S granted 35,890 warrants to employees on October 13, 2026.
- Each warrant allows subscription for one ordinary share at an exercise price of US $223.21.
- 25% of warrants vest one year after grant; remaining 75% vest monthly over 36 months.
- Warrants are subject to continued service and potential earlier vesting upon exit events.
- Approximately 1,459,173 shares remain available for future warrant grants.
Price Impact
More from ASND
Ascendis Pharma: TransCon CNP Orphan Drug Designation Recommended for Maintenance in EU
Ascendis Pharma: TransCon CNP Orphan Designation Recommended in Europe; EC Decision Due Q4 2026
Ascendis Pharma to Present Long-Term Data on Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026